Alcon (ALC) stock: Winston Score and insider trades
Alcon makes products that help people see better. Its two main businesses are surgical equipment and supplies used by eye doctors during procedures like cataract and retina surgery, and consumer eye care products like contact lenses and eye drops sold under brands such as Dailies and Systane. Alcon is one of the largest eye care companies in the world, focused entirely on vision — it does not make any other type of medical product. Alcon earns money by selling surgical devices and consumables to hospitals and clinics, and by selling contact lenses and eye drops directly to consumers through pharmacies and optometrists. The company operates globally, with strong sales in the United States, Europe, and growing markets in Asia. Its focus on a single specialty gives it deep relationships with eye surgeons and a broad product portfolio that competitors find hard to match all at once. The biggest growth driver is the aging global population, which increases demand for cataract surgeries and vision correction products over time.
Winston Score: 41 out of 100, Average
Mixed quality — meaningful strengths and weaknesses.
- Quality: Mixed (11/30)
- Growth: Mixed (5/20)
- Cash Flow: Exceptional (9/10)
- Stability: Strong (8/10)
- Valuation: Good (5/10)
- Ownership: Weak (2/15)
Key Facts
Price: $66.18
Market Cap: $32.0B
Sector: Healthcare
Industry: Medical - Specialties
Exchange: New York Stock Exchange
Editorial rules set and reviewed by Felix Prehn, Economist and Editor. Figures are refreshed daily from Financial Modeling Prep and company filings; last refreshed 2026-10-14.




